Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 29 | 1 | 47 | +19 |
| Shares | 20.8M | 3.19K | 22.0M | +1.15M (+5.5%) |
| Value | $127.2M | $20.0K | $198.7M | +$71.5M (+56.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| VR Adviser, LLC | 2,425,737 | $22.3M | 3.44% |
| Great Point Partners LLC | 674,656 | $6.20M | 1.49% |
| Paradigm Biocapital Advisors LP | 634,211 | $5.83M | 0.82% |
| Citadel Advisors LLC | 596,978 | $5.49M | 0.01% |
| Janus Henderson Group PLC | 560,168 | $5.14M | 0.00% |
| Valeo Financial Advisors, LLC | 75,500 | $694.0K | 0.04% |
| Bank of America Corp | 72,680 | $668.0K | 0.00% |
| Ensign Peak Advisors, Inc | 69,422 | $638.0K | 0.00% |
| Bank of Montreal | 48,100 | $446.0K | 0.00% |
| Marshall Wace, LLP | 30,898 | $284.0K | 0.00% |
| Fred Alger Management, LLC | 26,672 | $245.0K | 0.00% |
| Caption Management, LLC | 25,378 | $233.0K | 0.04% |
| Engineers Gate Manager LP | 11,800 | $108.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 11,600 | $107.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 11,499 | $106.0K | 0.00% |
| Group One Trading, L.P. | 4,248 | $39.0K | 0.00% |
| Cutler Group LP | 3,937 | $36.0K | 0.00% |
| Cowen and Company, LLC | 14,000 | $20.0K | 0.00% |
| CSS LLC | 1,008 | $9.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 137 | $1.00K | 0.00% |
| BlackRock Inc. | 5 | $0 | 0.00% |
Sold out (2)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| OrbiMed Advisors LLC | 1,817,521 | $11.2M |
| Acadian Asset Management LLC | 13,717 | $84.0K |
Not filed for Q3 2022 yet (1)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 3,194 | $20.0K |